Clinical Trials Directory

Trials / Completed

CompletedNCT03856281

Intermittent Pneumatic Compression for Treating Lower Limb Lymphoedema

Intermittent Pneumatic Compression for Treating Lower Limb Lymphoedema (IMPRESS II)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Cwm Taf University Health Board (NHS) · Other Government
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The treatment of lymphoedema and its associated complications represent a considerable drain on increasingly limited NHS resources. Intermittent pneumatic compression (IPC) represents an innovative treatment for this condition, however the efficacy of IPC as a treatment for lower limb lymphoedema needs to be investigated via robust clinical research.

Detailed description

The primary aim of this research is to evaluate the effectiveness of intermittent pneumatic compression (IPC) as a treatment for lower limb lymphoedema as a whole, and to compare the effectiveness of a new generation device, in this case the LymphAssist (Huntleigh Healthcare), against older sequential models. The study methodology consists of a pilot randomised control trial of two groups - Intervention group A will continue to receive their standard lymphoedema care but will also be provided with a LymphAssist IPC device to use, mimicking manual lymph drainage therapy. Participants in intervention group B will receive their standard care plus an IPC device that uses sequential therapy. Each participant will act as a control for a 5 week period continuing with their standard treatment only. Outcome measures include impact on limb volume, skin stiffness and elasticity score and impact on quality of life scores.

Conditions

Interventions

TypeNameDescription
DEVICEIntermittent Pneumatic CompressionParticipants administer an intermittent pneumatic compression device in addition to their standard lymphoedema care for a 5 week treatment period

Timeline

Start date
2018-07-10
Primary completion
2019-12-10
Completion
2019-12-10
First posted
2019-02-27
Last updated
2020-01-27

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03856281. Inclusion in this directory is not an endorsement.